SUSTAINED DRUG DELIVERY IMPLANT

생분해성 중합체 매트릭스는 브리모니딘 자유 염기 제제를 포함할 수 있으며, 눈 내로의 상기 생분해성 중합체 매트릭스의 방출을 상기 중합체 매트릭스로 촉진시키도록 상기 브리모니딘 자유 염기 제제와 결합된 생분해성 중합체는 약물 방출 기간보다 길지만 약물 방출 기간의 2배 이하인 기간 동안 지속한다. Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine fr...

Full description

Saved in:
Bibliographic Details
Main Authors SHIAH JANE GUO, PUJARA CHETAN P
Format Patent
LanguageEnglish
Korean
Published 23.10.2015
Subjects
BANDAGES, DRESSINGS OR ABSORBENT PADS
DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS
FILTERS IMPLANTABLE INTO BLOOD VESSELS
FIRST-AID KITS
FOMENTATION
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROSTHESES
TREATMENT OR PROTECTION OF EYES OR EARS
Online AccessGet full text

Cover

Abstract 생분해성 중합체 매트릭스는 브리모니딘 자유 염기 제제를 포함할 수 있으며, 눈 내로의 상기 생분해성 중합체 매트릭스의 방출을 상기 중합체 매트릭스로 촉진시키도록 상기 브리모니딘 자유 염기 제제와 결합된 생분해성 중합체는 약물 방출 기간보다 길지만 약물 방출 기간의 2배 이하인 기간 동안 지속한다. Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine free base to facilitate the release of the brimonidine free base into an eye with the polymer matrix lasts a period of time of not more than twice the drug release duration, but more than the drug release duration.
AbstractList 생분해성 중합체 매트릭스는 브리모니딘 자유 염기 제제를 포함할 수 있으며, 눈 내로의 상기 생분해성 중합체 매트릭스의 방출을 상기 중합체 매트릭스로 촉진시키도록 상기 브리모니딘 자유 염기 제제와 결합된 생분해성 중합체는 약물 방출 기간보다 길지만 약물 방출 기간의 2배 이하인 기간 동안 지속한다. Biocompatible intraocular implants may include a brimonidine free base and a biodegradable polymer associated with the brimonidine free base to facilitate the release of the brimonidine free base into an eye with the polymer matrix lasts a period of time of not more than twice the drug release duration, but more than the drug release duration.
Author SHIAH JANE GUO
PUJARA CHETAN P
Author_xml – fullname: SHIAH JANE GUO
– fullname: PUJARA CHETAN P
BookMark eNrjYmDJy89L5WSQDw4NDnH09HN1UXAJCnVXcHH18QxzDYpU8PQN8HH0C-FhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfHeQUYGhqYGhoaWRqYmjsbEqQIAR6YkVw
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
DocumentTitleAlternate 지속된 약물 전달 임플란트
ExternalDocumentID KR20150119254A
GroupedDBID EVB
ID FETCH-epo_espacenet_KR20150119254A3
IEDL.DBID EVB
IngestDate Fri Jul 19 14:35:15 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
Korean
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_KR20150119254A3
Notes Application Number: KR20157025053
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151023&DB=EPODOC&CC=KR&NR=20150119254A
ParticipantIDs epo_espacenet_KR20150119254A
PublicationCentury 2000
PublicationDate 20151023
PublicationDateYYYYMMDD 2015-10-23
PublicationDate_xml – month: 10
  year: 2015
  text: 20151023
  day: 23
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies ALLERGAN, INC
RelatedCompanies_xml – name: ALLERGAN, INC
Score 2.9794405
Snippet 생분해성 중합체 매트릭스는 브리모니딘 자유 염기 제제를 포함할 수 있으며, 눈 내로의 상기 생분해성 중합체 매트릭스의 방출을 상기 중합체 매트릭스로 촉진시키도록 상기 브리모니딘 자유 염기 제제와 결합된 생분해성 중합체는 약물 방출 기간보다 길지만 약물 방출 기간의 2배 이하인 기간...
SourceID epo
SourceType Open Access Repository
SubjectTerms BANDAGES, DRESSINGS OR ABSORBENT PADS
DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF,TUBULAR STRUCTURES OF THE BODY, E.G. STENTS
FILTERS IMPLANTABLE INTO BLOOD VESSELS
FIRST-AID KITS
FOMENTATION
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROSTHESES
TREATMENT OR PROTECTION OF EYES OR EARS
Title SUSTAINED DRUG DELIVERY IMPLANT
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151023&DB=EPODOC&locale=&CC=KR&NR=20150119254A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwY2BQSTQH1erJxrqGKUnJuibGiaa6lkbJhrrGFqmWJsDqI8UyETQ04Otn5hFq4hVhGsHEkAPbCwM-J7QcfDgiMEclA_N7Cbi8LkAMYrmA11YW6ydlAoXy7d1CbF3UoL1jYPUFrIPUXJxsXQP8Xfyd1Zydbb2D1PyCwHKg482A_SFHZgZWUEMadNK-a5gTaF9KAXKl4ibIwBYANC-vRIiBKTtfmIHTGXb3mjADhy90yhvIhOa-YhEG-eDQ4BBHTz9XFwWXoFB3BRdXH88w16BIBU_fAB9HvxBRBmU31xBnD12gTfFwj8V7ByE7y1iMgQXY5U-VYFCwsEw1NjZPSUu0SEo2SU1LtExLtgRmrKS05FRQj8BckkEGn0lS-KWlGbhAXFAJbGQsw8BSUlSaKgusWkuS5MAhAgDZI3ht
link.rule.ids 230,309,786,891,25594,76906
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7Uaqw3rRof1ZJouBHTLpVyIIayIFigDYWmnggskBiNbSzGv-8sodpTb5udZPaRzHz7ze7MAtwnCkd1RqReljJJJslAUvusJ5FhrsoIH5ma8NCA5z_akfyyGCwa8LHJhanqhP5UxRHRohjae1n569V_EItWbyvXD-kbdi2frFCjYs2OEb4Qg0Q60szphE4M0TC0cSD6QSXj5c2QD-l7sK_w-rz88DQf8byU1TaoWMdwMEV9n-UJNN6XbWgZm7_X2nDo1Vfe2Kytb30K3Vk0C3XHN6lAg-hZoKbrzM3gVXC8qav74RncWWZo2BKOFP8tLB4H29Mi59BEyp9fgDBUc0KUrEiGKZPzIlELpqJhpQXLOSNQLqGzS9PVbnEXWnboubHr-ONrOOIi7o37pAPN8us7v0GYLdPband-AaL8e1o
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=SUSTAINED+DRUG+DELIVERY+IMPLANT&rft.inventor=SHIAH+JANE+GUO&rft.inventor=PUJARA+CHETAN+P&rft.date=2015-10-23&rft.externalDBID=A&rft.externalDocID=KR20150119254A